HT BioImaging
Imaging Method for Early Cancer Detection
Company Overview
Snapshot
Founded in September 2015 by Gideon Barak and Shani Toledano, HT BioImaging operates with 11–50 employees. The company has raised $5.5M across three funding rounds from six investors. In March 2022, Companion Animal Health made a strategic investment in the company, highlighting its potential in early cancer detection solutions.
Business overview
HT BioImaging is a Health Tech & Life Sciences company developing a medical imaging platform for early, on-the-spot cancer detection and classification. Its core technology is the heat diffusion imaging (HDI) scan, a system that measures heat diffusion in biological tissues. This non-invasive technology translates heat diffusion signals into an image, enabling real-time cancer detection at the point of care and in operating rooms. The company serves the healthcare industry, including hospitals, clinics, and veterinary practices, operating within the digital healthcare, diagnostics, and oncology sectors.
Strategic signal
In March 2022, Companion Animal Health announced a strategic investment in HT BioImaging, signaling strong validation for the company's early cancer detection solution. This investment suggests a growing interest in advanced diagnostic technologies within the animal health sector, potentially opening new market avenues and accelerating the development and adoption of HT BioImaging's HDI scan technology for broader applications.
Company Intelligence Q&A
- What is HT BioImaging's core technology?
- HT BioImaging's core technology is the heat diffusion imaging (HDI) scan, a system designed to measure heat diffusion in biological tissues for early, non-invasive cancer detection.
- When was HT BioImaging founded?
- HT BioImaging was founded in September 2015 by Gideon Barak and Shani Toledano.
- What was a significant recent investment in HT BioImaging?
- In March 2022, Companion Animal Health made a strategic investment in HT BioImaging, focusing on its early cancer detection solution.
- Which investors participated in HT BioImaging's July 2020 funding round?
- In July 2020, HT BioImaging received funding from NextLeap Ventures and Magna Capital Partners.
- What markets does HT BioImaging target?
- HT BioImaging targets geomarkets including Canada, Europe, and the United States with its medical imaging solutions.